Preventive Measures and Management of Catheter-Associated Urinary Tract Infection in Adult Intensive Care Units in Saudi Arabia.


Journal

Journal of epidemiology and global health
ISSN: 2210-6014
Titre abrégé: J Epidemiol Glob Health
Pays: Switzerland
ID NLM: 101592084

Informations de publication

Date de publication:
06 2021
Historique:
received: 12 10 2020
accepted: 15 04 2021
pubmed: 11 5 2021
medline: 25 8 2021
entrez: 10 5 2021
Statut: ppublish

Résumé

Catheter-associated Urinary Tract Infection (CAUTI) has been studied worldwide as part of device-related healthcare infection. CAUTI is one of the most commonly reported infections in the literature, which occurs during clinical practice in Intensive Care Units (ICUs) and non-ICU departments. Many studies have covered the CAUTI rate in Saudi Arabia mainly in the ICU covering single or multiple hospitals as surveillance for device-related infections in the ICU. Few studies have conducted an interventional approach that examined the implementation of infection control protocols and then compared them to international practice as a standard. This review aims to explore the literature to provide insight into the infection control practices that have been reported in Saudi Arabia during the last two decades on the preventive measures and clinical consequences of CAUTIs. Very few studies have recorded the pattern of resistant microorganisms that burdens clinical practice in ICUs concerning CAUTIs. Only one study compared the type of catheter materials and discussed the effect of these materials on reducing CAUTIs. It is essential to cover catheter utilization and to understand how a sufficient infection control protocol with educational programs for healthcare personnel can transform practice, for the better, regarding CAUTI rates in Saudi hospitals. There is a demand for more interventional and epidemiological studies on the causes and factors affecting the rate of CAUTI in the area. Studies may help reduce the CAUTI incidence rate, which consequently reduces the costs and morbidity associated with this type of infection and other healthcare-related infections.

Identifiants

pubmed: 33969947
pii: jegh.k.210418.001
doi: 10.2991/jegh.k.210418.001
pmc: PMC8242112
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

164-168

Informations de copyright

© 2021 The Author. Published by Atlantis Press International B.V.

Déclaration de conflit d'intérêts

The author declares no conflicts of interest.

Références

Am J Infect Control. 2014 Oct;42(10):1056-61
pubmed: 25278393
Am J Infect Control. 2017 Oct 1;45(10):1143-1153
pubmed: 28476493
Saudi Med J. 2018 Jan;39(1):97-102
pubmed: 29332116
Antimicrob Resist Infect Control. 2017 Jan 5;6:3
pubmed: 28070310
Chemotherapy. 2009;55(2):127-31
pubmed: 19188712
Interv Med Appl Sci. 2017 Sep;9(3):137-143
pubmed: 29201437
Am J Infect Control. 2020 Apr;48(4):423-432
pubmed: 31676155
J Epidemiol Glob Health. 2018 Mar;7 Suppl 1:S35-S40
pubmed: 29801591
J Infect Public Health. 2014 Jul-Aug;7(4):339-44
pubmed: 24861643
Acta Biomater. 2017 Mar 1;50:20-40
pubmed: 27916738
Infect Dis Clin North Am. 2016 Dec;30(4):869-885
pubmed: 27816141
Infect Control Hosp Epidemiol. 2011 Aug;32(8):748-56
pubmed: 21768757
Cochrane Database Syst Rev. 2012 Oct 17;10:CD004997
pubmed: 23076911
Urol Ann. 2016 Oct-Dec;8(4):423-429
pubmed: 28057985
Crit Care Clin. 2013 Jan;29(1):19-32
pubmed: 23182525
Am J Infect Control. 2016 Dec 1;44(12):1589-1594
pubmed: 27692786
Int J Infect Dis. 2013 Dec;17(12):e1207-11
pubmed: 23932872
Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004203
pubmed: 16034924
Biomed Res Int. 2016;2016:7026169
pubmed: 27999811
N Engl J Med. 2016 Jun 2;374(22):2111-9
pubmed: 27248619
N Engl J Med. 2018 Nov 1;379(18):1732-1744
pubmed: 30380384

Auteurs

Najla A Obaid (NA)

College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH